Published
Combining NVIDIA's world-leading accelerated computing and Schrödinger's novel drug discovery platform enables rapid, accurate evaluation of billions of molecules for the potential development of therapeutics, reducing the cost of preclinical drug discovery. Learn more: https://nvda.ws/3fUH2JF
#drugresearch #drugdevelopment #machinelearning
#drugresearch #drugdevelopment #machinelearning
Sign in or sign up to post comments.
Be the first to comment
Up Next
-
01:19
Using AI to Accelerate Scientific Discovery
-
01:14
Altair and NVIDIA GPUs Accelerate Design Simulation
-
04:32
Unilever and Microsoft are teaming-up to accelerate scientific discovery
-
02:36
How NVIDIA GPUs Accelerate Adobe Illustrator CC
-
00:40
Drug Discovery Set for Deep Learning Transformation Powered by GPUs
-
01:31
Accelerate Production Ready AI with NVIDIA AI Enterprise
-
02:13
Accelerate AI Workloads for Healthcare with NVIDIA and VMware
-
02:24
Accelerate AI-Powered Drug Discovery With NVIDIA BioNeMo
-
07:43
Accelerate Innovation with NVIDIA and Dell Technologies
-
02:33
Genentech and NVIDIA Revolutionize Drug Discovery with Generative AI in Lab in the Loop
-
03:54
Worldwide Partner Conference: Day 1 Recap
-
13:04
Satya Nadella: Worldwide Partner Conference 2016
-
03:29
U.S. Building 2 Flagship Supercomputers to Accelerate Scientific Discovery
-
03:32
U.S. Building Two Flagship Supercomputers to Accelerate Scientific Discovery
-
02:07
Accelerate Breakthroughs with NVIDIA GPU Cloud
-
02:06
NVIDIA and Arm Accelerate HPC Worldwide
-
01:07
Intel and NVIDIA Accelerate Professional Workstation Performance
-
01:14
GSK and NVIDIA Partner on AI-Powered Lab for Discovery of Medicines and Vaccines
-
02:20
AstraZeneca: Accelerating Drug Discovery with Machine Learning and AI on Cambridge-1
-
01:46
Accelerate Production-Ready AI with NVIDIA AI Enterprise
-
04:27
Microsoft Azure Quantum and PNNL join forces to accelerate scientific discovery
-
01:12
Generative AI for Drug Discovery and Design
Loading...